C50
Conditions
Interventions
Group 1: 64 patients from mammography screening in 2013 and 34 patients from the curative sector - Senologie Helios Klinikum Krefeld from 2013. On the one hand, data will be retrospectively evaluated
Sponsors
Helios Klinikum Krefeld - Institut für Pathologie
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Malignant tumor of the mammary gland
Exclusion criteria
Exclusion criteria: No follow-up data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary project goal is the functional in situ characterization of mast cells and the mast cell-specific enzymes. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary project goal discusses whether there is any evidence to block the interaction of vasoactive substances in the tumor area with mast cell stabilizers. Furthermore, a secondary project goal would be to determine whether effects could be achieved with increased levels of histamine decarboxylase with histamine blockers. | — |
Countries
Germany
Contacts
Public ContactBernhard Hemmerlein
Helios Klinikum Krefeld
Outcome results
None listed